HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Equity Capital Markets

<ul>
<li>The essence of SIRIO’s business model is CDMO in the field of nutrition and health food, providing global brand owners with one-stop solutions from R&amp;D, manufacturing, packaging to marketing support.</li>
<li>The CDMO model enables SIRIO to quickly enter the global supply chain and achieve scale expansion through light-asset operations.But the stability of revenue is greatly affected by customers’ strategic adjustments.  </li>
<li>In the context of intensified homogenized competition, profit margins are easily compressed. SIRIO's equity incentive plan reflects its concerns about future growth prospects after experiencing a significant decline in 2025.</li>
</ul>


The essence of SIRIO’s business model is CDMO in the field of nutrition and health food, providing global brand owners with one-stop solutions from R&amp;D, manufacturing, packaging to marketing support.
The CDMO model enables SIRIO to quickly enter the global supply chain and achieve scale expansion through light-asset operations.But the stability of revenue is greatly affected by customers’ strategic adjustments.  
In the context of intensified homogenized competition, profit margins are easily compressed. SIRIO's equity incentive plan reflects its concerns about future growth prospects after experiencing a significant decline in 2025.


Pre-IPO Sirio Pharma (A/H Listing) - About the Business Model and the Outlook

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Sirio Pharma (SIRIO HK)

Pre-IPO Sirio Pharma (A/H Listing) - About the Business Model and the Outlook

SIRIO's CDMO model offer one-stop solution for customers but face challenges with revenue stability/profit space in competitive market.The equity...

Xinyao (Criss) Wang

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Pre-IPO Sirio Pharma (A/H Listing) - About the Business Model and the Outlook

​SIRIO's CDMO model offer one-stop solution for customers but face challenges with revenue stability/profit space in competitive market.The equity...

Xinyao (Criss) Wang

SIRIO's CDMO model offer one-stop solution for customers but face challenges with revenue stability/profit space in competitive market.The equity...